483
Renalytix AI, Inc.FDA 483 - Renalytix AI, Inc. - April 11, 2025
Discuss this record with AI
Document or profile
One record shows the event. A profile shows the pattern.
Buy this document for the source file and details behind this single event.
Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.
Record Details
An FDA inspection of Renalytix AI, Inc. in New York, NY, identified two significant issues. The firm's complaint management procedures were found to be inadequate, specifically lacking mention of uniform and timely complaint processing. Additionally, the company had not implemented written Medical Device Reporting (MDR) procedures and could not provide proof of an active Electronic Submission Gateway account for electronic MDR submissions.
- Office
- New York District Office
- Person
Open in Dashboard
ID · 7c14ccd0-caf4-4565-8f86-31ba360441cc